Fulcrum Capital LLC Has $8.28 Million Position in Zoetis Inc. (NYSE:ZTS)

Fulcrum Capital LLC grew its position in Zoetis Inc. (NYSE:ZTS) by 3.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 50,818 shares of the company’s stock after buying an additional 1,575 shares during the quarter. Zoetis accounts for about 1.7% of Fulcrum Capital LLC’s portfolio, making the stock its 19th largest holding. Fulcrum Capital LLC’s holdings in Zoetis were worth $8,280,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Darwin Wealth Management LLC bought a new stake in Zoetis during the 3rd quarter worth approximately $31,000. First Personal Financial Services bought a new stake in Zoetis during the 3rd quarter worth approximately $33,000. Capital Performance Advisors LLP bought a new stake in Zoetis during the 3rd quarter worth approximately $33,000. Dunhill Financial LLC grew its holdings in Zoetis by 80.6% during the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after acquiring an additional 75 shares during the last quarter. Finally, Quarry LP grew its holdings in Zoetis by 273.2% during the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after acquiring an additional 153 shares during the last quarter. 92.80% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ZTS has been the topic of a number of research reports. UBS Group initiated coverage on shares of Zoetis in a research report on Monday, December 9th. They set a “neutral” rating and a $196.00 target price on the stock. Leerink Partners initiated coverage on shares of Zoetis in a research report on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price on the stock. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Stifel Nicolaus dropped their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of $211.89.

Zoetis Stock Up 1.8 %

Shares of NYSE ZTS traded up $2.92 during trading on Monday, hitting $166.24. The stock had a trading volume of 1,258,830 shares, compared to its average volume of 2,338,915. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27. The company has a market capitalization of $75.00 billion, a PE ratio of 31.25, a PEG ratio of 2.91 and a beta of 0.89. The firm has a fifty day moving average of $171.71 and a two-hundred day moving average of $180.29.

Zoetis (NYSE:ZTS) last posted its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.36 EPS. As a group, equities research analysts forecast that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 1.20%. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s dividend payout ratio is presently 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.